0

Journal Articles

in Diabetes Mellitus Type 2
 141-160 of 265 Articles
Original Contribution |  July 26, 2006 FREE
Effect of Youth-Onset Type 2 Diabetes Mellitus on Incidence of End-Stage Renal Disease and Mortality in Young and Middle-Aged Pima Indians
Meda E. Pavkov, MD, PhD; Peter H. Bennett, MB, FRCP; William C. Knowler, MD, DrPH; et al.
JAMA. 2006;296(4):421-426. doi:10.1001/jama.296.4.421.
Review |  July 26, 2006 FREE
Effects of Quality Improvement Strategies for Type 2 Diabetes on Glycemic Control:  A Meta-Regression Analysis
Kaveh G. Shojania, MD; Sumant R. Ranji, MD; Kathryn M. McDonald, MM; et al.
JAMA. 2006;296(4):427-440. doi:10.1001/jama.296.4.427.
Capitol Health Call |  July 12, 2006
NIH, CDC Budget Squeeze
JAMA. 2006;296(2):161. doi:10.1001/jama.296.2.161-b.
Medical News and Perspectives |  June 14, 2006
Signaling Proteins Boost Drug Activity
JAMA. 2006;295(22):2590. doi:10.1001/jama.295.22.2590.
Original Contribution |  May 03, 2006 FREE
Disease and Disadvantage in the United States and in England
James Banks, PhD; Michael Marmot, MD; Zoe Oldfield, MSc; et al.
JAMA. 2006;295(17):2037-2045. doi:10.1001/jama.295.17.2037.
Grand Rounds |  April 26, 2006
Using Clinical Guidelines Designed for Older Adults With Diabetes Mellitus and Complex Health Status
Samuel C. Durso, MD
JAMA. 2006;295(16):1935-1940. doi:10.1001/jama.295.16.1935.
INCLUDES: CME
Preliminary Communication |  April 12, 2006 FREE
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
Louis Monnier, MD; Emilie Mas, PhD; Christine Ginet, MD; et al.
JAMA. 2006;295(14):1681-1687. doi:10.1001/jama.295.14.1681.
Review |  March 15, 2006 FREE
Sex Differences of Endogenous Sex Hormones and Risk of Type 2 Diabetes:  A Systematic Review and Meta-analysis
Eric L. Ding, BA; Yiqing Song, MD, ScD; Vasanti S. Malik, MSc; et al.
JAMA. 2006;295(11):1288-1299. doi:10.1001/jama.295.11.1288.
INCLUDES: CME
JAMA Patient Page |  February 22, 2006 FREE
Irritable Bowel Syndrome
Janet M. Torpy, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2006;295(8):960. doi:10.1001/jama.295.8.960.
INCLUDES: , Supplemental Content
Medical News and Perspectives |  January 18, 2006
Performance Measurements Stressed as Benchmarks for Improving US Health Care
JAMA. 2006;295(3):264. doi:10.1001/jama.295.3.264.
From the Centers for Disease Control and Prevention |  January 04, 2006 FREE
Mobility Limitation Among Persons Aged ≥40 Years With and Without Diagnosed Diabetes and Lower Extremity Disease—United States, 1999-2002
JAMA. 2006;295(1):25-30. doi:10.1001/jama.295.1.29.
From the Centers for Disease Control and Prevention |  December 21, 2005 FREE
Incidence of End-Stage Renal Disease Among Persons With Diabetes—United States, 1990-2002
JAMA. 2005;294(23):2962-2963. doi:10.1001/jama.294.23.2962.
Original Contribution |  November 23, 2005 FREE
Duration of Lactation and Incidence of Type 2 Diabetes
Alison M. Stuebe, MD; Janet W. Rich-Edwards, ScD; Walter C. Willett, MD, DrPH; et al.
JAMA. 2005;294(20):2601-2610. doi:10.1001/jama.294.20.2601.
Original Contribution |  November 23, 2005 FREE
Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
Steven E. Nissen, MD; Kathy Wolski, MPH; Eric J. Topol, MD
JAMA. 2005;294(20):2581-2586. doi:10.1001/jama.294.20.joc50147.
The World in Medicine |  November 16, 2005
Preventing Chronic Disease
JAMA. 2005;294(19):2423. doi:10.1001/jama.294.19.2423-c.
Review |  July 06, 2005 FREE
Coffee Consumption and Risk of Type 2 Diabetes:  A Systematic Review
Rob M. van Dam, PhD; Frank B. Hu, MD, PhD
JAMA. 2005;294(1):97. doi:10.1001/jama.294.1.97.
INCLUDES: CME
Brief Report |  May 04, 2005 FREE
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
Ioannis Iakovou, MD; Thomas Schmidt, MD; Erminio Bonizzoni, PhD; et al.
JAMA. 2005;293(17):2126-2130. doi:10.1001/jama.293.17.2126.
Medical News and Perspectives |  April 20, 2005
Diabetes Management Remains Suboptimal
JAMA. 2005;293(15):1845-1846. doi:10.1001/jama.293.15.1845.
Clinical Review |  March 23, 2005 FREE
Diabetes and Coronary Revascularization
James D. Flaherty, MD; Charles J. Davidson, MD
JAMA. 2005;293(12):1501-1508. doi:10.1001/jama.293.12.1501.
INCLUDES: CME
Health Agencies Update |  January 26, 2005
Islet Precursor Cells
JAMA. 2005;293(4):415. doi:10.1001/jama.293.4.415-c.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Correction  |  May 13, 2013
Error in Table in: Communication and Medication Refill Adherence: The Diabetes Study of Northern California
JAMA Internal Medicine
Viewpoint  |  April 22, 2013
Nullius In Verba:  Don't Take Anyone's Word for It
Richard S. Lehman, MA, BM,  BCh, MRCGP
JAMA Internal Medicine
Original Investigation  |  February 25, 2013
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Internal Medicine
Invited Commentary  |  March 5, 2013
Glucagonlike Peptide 1–Based Drugs and Pancreatitis:  Clarity at Last, but What About Pancreatic Cancer?
Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus”
Belinda Gier, PhD; Peter C. Butler, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems